Oligo-arthritis and type IV hyperlipoproteinemia.
The increased risk of cardiovascular mortality in patients with inflammatory joint disease indicates a need for routine investigations to detect conventional cardiovascular risk factors. These investigations may provide the classification of the disease. We report a case of oligoarticular arthritis with type IV hyperlipoproteinemia, a condition of which only 15 cases are described in the literature. The patient had oligoarthritis, laboratory signs of severe inflammation, and type IV hyperlipoproteinemia (triglycerides, 24.6 mmol/L; and total cholesterol, 10.7 mmol/L). The clinical and laboratory test abnormalities resolved under fenofibrate therapy.
Soubrier
Martin
M
Hôpital Gabriel Montpied, Service de Rhumatologie, Place Henri Dunant, BP 69, Clermont-Ferrand, F-63003, France. msoubrier@chu-clermontferrand.fr
Dubost
Jean Jacques
JJ
Thiéblot
Philippe
P
Ristori
Jean Michel
JM
D000125:Achilles Tendon / Q000473:pathology; D001168:Arthritis / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D002784:Cholesterol / Q000097:blood; D005260:Female; D011345:Fenofibrate / Q000627:therapeutic use; D006801:Humans; D006953:Hyperlipoproteinemia Type IV / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood
D000960:Hypolipidemic Agents; D014280:Triglycerides; D002784:Cholesterol; D011345:Fenofibrate